Online Images in the Medical Sciences| Volume 365, ISSUE 4, e65-e66, April 2023

Growing teratoma syndrome - ovarian germ cell tumor

Published:November 04, 2022DOI:
      A 28-year-old woman presented with pain and a mass in the abdomen for three months. The mass was was diagnosed as a mixed germ cell tumour (grade 3 immature teratoma and yolk sac tumour - FIGO stage IIIC). She underwent cytoreductive surgery, and three months later, she presented with a recurrent abdominal lump. Contrast-enhanced computed tomography (CECT) scan showed multiple deposits in the peritoneum, the largest measuring 23 × 17 × 12cm (Fig. 1A) and elevated tumour markers (Alpha Feto Protein (AFP): 3080ng/ml). She received two lines of chemotherapy [Bleomycin, Etoposide and Cisplatin (BEP) and Vinblastine, Ifosfamide & Cisplatin (VeIP)]. Post-chemotherapy, the patient's symptoms worsened with increasing abdominal distension. CECT scan showed an increase in the size of the lesion (Fig. 1B). However, the tumour markers were normal (AFP 8.34 ng/ml). She underwent a second-look laparotomy with complete cytoreduction. Pathology revealed only elements of mature teratoma with elements of all three germ cell layers (respiratory epithelium, mucinous glands, cartilage and mature glial tissue forming nodules in the peritoneum) (Fig. 2A-D).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect